|
|
|
|
|
Legal status
Patent in force
| (51) | INT.CL. | A61K 31/497 | (2006.01) |
| A61K 9/20 | (2006.01) | ||
| A61K 47/10 | (2017.01) | ||
| A61K 47/26 | (2006.01) | ||
| A61P 35/00 | (2006.01) |
| (11) | Number of the document | 3318259 |
| (13) | Kind of document | T |
| (96) | European patent application number | 16821324.7 |
| Date of filing the European patent application | 2016-07-01 | |
| (97) | Date of publication of the European application | 2018-05-09 |
| (45) | Date of publication and mention of the grant of the patent | 2023-01-11 |
| (46) | Date of publication of the claims translation | 2023-05-10 |
| (86) | Number | PCT/JP2016/069615 |
| Date | 2016-07-01 |
| (87) | Number | WO 2017/006855 |
| Date | 2017-01-12 |
| (30) | Number | Date | Country code |
| 2015134817 | 2015-07-03 | JP |
| (72) |
MIYAZAKI, Masakazu , JP
ISHIBA, Ryohei , JP
TAKAISHI, Yuki , JP
UEJO, Fumiaki , JP
|
| (73) |
Astellas Pharma Inc. ,
5-1, Nihonbashi-Honcho 2-chome, Chuo-ku
Tokyo 103-8411,
JP
|
| (74) |
Aušra PAKĖNIENĖ,
AAA Law, A. Goštauto g. 40B, Verslo centras "Dvyniai", LT-03163 Vilnius,
LT
|
| (54) | Stabili farmacinė kompozicija, skirta peroraliniam vartojimui |
| STABLE PHARMACEUTICAL COMPOSITION FOR ORAL ADMINISTRATION |
| Payment date | Validity (years) | Amount | |
| 2025-06-18 | 10 | 231.00 EUR |
| 2026-07-01 |